MENLO PARK, Calif., March 14, 2017 -- Landec Corporation (Nasdaq:LNDC) will hold a conference call on Wednesday April 5, 2017 at 8 a.m. Pacific time to discuss its results for the third quarter fiscal 2017. Financial results will be reported for the 2017 fiscal third quarter ended February 26, 2017 after market close on April 4, 2017.
Landec's President and CEO, Molly Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.
Date: Wednesday April 5, 2017
Time: 8 a.m. Pacific time (11 a.m. Eastern time)
Toll Free Participant Dial-in Number: (844) 860-6243
U.S. and International Toll Number: (661) 378-9884
Conference ID: 87473692
Webcast: http://ir.Landec.com/events.cfm
The webcast will be available for 30 days through May 5, 2017.
A replay of the teleconference will be available for one week until midnight Eastern time, Wednesday April 12, 2017.
Toll free replay dial in: (855) 859-2056
International replay: (404) 537-3406
Replay passcode: 87473692
About Landec Corporation
Landec Corporation (NASDAQ:LNDC) is a leading innovator of diversified health and wellness solutions within the packaged natural food and biomaterial markets. Apio, Landec's food business, is the leader in branded, packaged fresh vegetables in North America, utilizing its proprietary BreatheWay® packaging technology to naturally extend the shelf life of fresh produce. Apio combines this technology with the capabilities of a large national fresh produce supplier to offer healthy fresh vegetable products under the Eat Smart® brand to consumers through club and retail grocery stores. Landec recently acquired O Olive Inc. that offers organic and natural olive oils and vinegars under the O brand. Lifecore Biomedical, Landec's biomaterial business, is a fully integrated Contract Development and Manufacturing Organization (CDMO) that offers expertise and capabilities in fermentation, specialty formulation, aseptic filling and final packaging for FDA regulated medical devices and drugs to customers for applications in a wide array of markets including Ophthalmic, Orthopedic and Oncology. For more information about the company, visit Landec's website at www.landec.com.
Media and Industry Contact: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: ICR, Inc. John Mills, Partner (646) 277-1254 [email protected]


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



